Table 2.

Relationship Between Neutrophil-to-Lymphocyte Ratio and Liver Fibrosis

Outcome	Crude Model		Model I		Model II
	OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
NLR	1.15 (1.03-1.29)	.012	1.12 (1.00-1.26)	.049	1.01 (0.82-1.24)	.914
NLR (quartile)
Q1	Reference		Reference		Reference
Q2	1.20 (0.85-1.68)	.299	1.19 (0.84-1.68)	.327	1.04 (0.57-1.90)	.897
Q3	1.55 (1.12-2.15)	.009	1.47 (1.04-2.06)	.027	1.17 (0.65-2.09)	.600
P for trend	.008		.026		.590

Model I adjusted for age, sex, race. Model II adjusted for age, sex, race, education level, body mass index, physical activity, smoking status, alanine transaminase, aspartate aminotransferase, alkaline phosphatase, gamma glutamyl transferase, total bilirubin, triglyceride–glucose index, hypertension, and diabetes.

NLR, neutrophil-to-lymphocyte ratio; OR, odds ratio.